Nonalcoholic fatty future disease

被引：62
|
作者：
Polyzos, Stergios A. [1 ]
Mantzoros, Christos S. [2 ,3 ]
机构：
[1] Aristotle Univ Thessaloniki, Med Clin 2, Ippokration Hosp, Thessaloniki, Greece
[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Internal Med, Div Endocrinol Diabet & Metab, Boston, MA USA
[3] Boston VA Healthcare Syst, Boston, MA USA
来源：
METABOLISM-CLINICAL AND EXPERIMENTAL | 2016年 / 65卷 / 08期
基金：
欧盟地平线“2020”;
关键词：
Noninvasive indices; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Simple steatosis; Treatment; LIVER-DISEASE; INSULIN SENSITIVITY; HEPATIC STEATOSIS; OXIDATIVE STRESS; LIPID-METABOLISM; UNITED-STATES; MICE; STEATOHEPATITIS; ACCUMULATION; EXPRESSION;
D O I：
10.1016/j.metabol.2015.12.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1007 / 1016
页数：10
相关论文
共 50 条
  • [1] The Future of Nonalcoholic Fatty Liver Disease Treatment
    Mazhar, Khurram
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2019, 103 (01) : 57 - +
  • [2] Statins and nonalcoholic fatty liver disease: a bright future?
    Athyros, Vasilios G.
    Katsiki, Niki
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (09) : 1089 - 1093
  • [3] Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Younossi, Zobair M.
    Loomba, Rohit
    Rinella, Mary E.
    Bugianesi, Elisabetta
    Marchesini, Giulio
    Neuschwander-Tetri, Brent A.
    Serfaty, Lawrence
    Negro, Francesco
    Caldwell, Stephen H.
    Ratziu, Vlad
    Corey, Kathleen E.
    Friedman, Scott L.
    Abdelmalek, Manal F.
    Harrison, Stephen A.
    Sanyal, Arun J.
    Lavine, Joel E.
    Mathurin, Philippe
    Charlton, Michael R.
    Chalasani, Naga P.
    Anstee, Quentin M.
    Kowdley, Kris V.
    George, Jacob
    Goodman, Zachary D.
    Lindor, Keith
    [J]. HEPATOLOGY, 2018, 68 (01) : 361 - 371
  • [4] Past, present and future perspectives in nonalcoholic fatty liver disease
    Sanyal, Arun J.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2019, 16 (06) : 377 - 386
  • [5] Nonalcoholic fatty liver disease - current status and future directions
    Demir, Muenevver
    Lang, Sonja
    Steffen, Hans-Michael
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2015, 16 (10) : 541 - 557
  • [6] Past, present and future perspectives in nonalcoholic fatty liver disease
    Arun J. Sanyal
    [J]. Nature Reviews Gastroenterology & Hepatology, 2019, 16 : 377 - 386
  • [7] MRI Biomarkers and Their Future Impact on Nonalcoholic Fatty Liver Disease
    Kozaka, Kazuto
    Matsui, Osamu
    [J]. RADIOLOGY, 2023, 309 (01)
  • [8] Molecular Signatures of Nonalcoholic Fatty Liver Disease: The Present and Future
    Yilmaz, Yusuf
    Ulukaya, Engin
    [J]. HEPATOLOGY, 2010, 51 (05) : 1866 - 1866
  • [9] Nonalcoholic Fatty Liver Disease Is Related to Nonalcoholic Fatty Pancreas Disease
    van Geenen, Erwin-Jan M.
    Smits, Mark M.
    Schreuder, Tim C. M. A.
    van der Peet, Donald L.
    Bloemena, Elisabeth
    Mulder, Chris J. J.
    [J]. PANCREAS, 2010, 39 (08) : 1185 - 1190
  • [10] Therapy for Nonalcoholic Fatty Liver Disease: Current Options and Future Directions
    Campbell, Patrick
    Symonds, Allison
    Barritt, A. Sidney
    [J]. CLINICAL THERAPEUTICS, 2021, 43 (03) : 500 - 517
12345